National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)

This guideline applies to cervical squamous cell carcinoma, adenocarcinoma and adenosquamous carcinoma, which accounts for more than 90% of cervical cancers. Current treatment strategies are influenced by a combination of hospital equipment, technical and patient’s condition.